Literature DB >> 23968761

Coronary revascularization for patients with severe left ventricular dysfunction.

Jeevan Nagendran1, Colleen M Norris, Michelle M Graham, David B Ross, Roderick G Macarthur, Teresa M Kieser, Andrew M Maitland, Danielle Southern, Steven R Meyer.   

Abstract

BACKGROUND: The efficacy of coronary artery bypass graft surgery (CABG) and percutaneous coronary intervention (PCI) in patients with coronary artery disease has been well defined by randomized controlled trials. However, patients with severe left ventricular dysfunction (ejection fraction <35%) were underrepresented in these trials, and management of these complex patients remains unclear. The purpose of this study was to compare the outcomes of patients with coronary artery disease and left ventricular dysfunction undergoing CABG versus PCI.
METHODS: The Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH), a clinical data collection and outcome monitoring initiative for the province of Alberta, Canada, was used to identify 2925 patients with coronary artery disease and left ventricular dysfunction undergoing CABG (n = 1,326) or PCI (n = 1,599) between 1995 and 2008. Patients were propensity matched to obtain comparable subgroups among left ventricular dysfunction patients.
RESULTS: Cox proportional hazard analysis of the propensity-matched subgroups identified that CABG was significantly associated with lower rates of repeat revascularization and better survival compared with PCI at 1, 5, 10, and 15 years. Other significant independent predictors of poor long-term survival included age, renal failure, heart failure, diabetes mellitus, peripheral vascular disease, prior myocardial infarction, left main coronary artery disease, and prior CABG.
CONCLUSIONS: For patients with coronary artery disease and left ventricular dysfunction, CABG was associated with lower rates of repeat revascularization and improved survival over PCI, after adjustment for baseline risk profile differences. Further research exploring the factors leading to use of a particular revascularization modality in this patient population is required.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  23; CABG; CAD; CI; DES; EF; HR; LVD; PCI; confidence interval; coronary artery bypass graft surgery; coronary artery disease; drug-eluting stent; ejection fraction; hazard ratio; left ventricular dysfunction; percutaneous coronary intervention

Mesh:

Year:  2013        PMID: 23968761     DOI: 10.1016/j.athoracsur.2013.06.052

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

1.  Predictors of immediate and long-term outcomes of coronary bypass surgery in patients with left ventricular dysfunction.

Authors:  Giuseppe Gatti; Luca Maschietto; Luca Dell'Angela; Bernardo Benussi; Gabriella Forti; Lorella Dreas; Petar Soso; Marco Russo; Gianfranco Sinagra; Aniello Pappalardo
Journal:  Heart Vessels       Date:  2015-07-15       Impact factor: 2.037

2.  Managing Heart Failure Patients with Multivessel Disease - Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention.

Authors:  John Pepper
Journal:  Card Fail Rev       Date:  2015-10

Review 3.  Myocardial ischemia and coronary disease in heart failure.

Authors:  Beniamino R Pagliaro; Francesco Cannata; Giulio G Stefanini; Leonardo Bolognese
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

4.  Recovery of Left Ventricular Function After Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Grafting in Patients with Multi-Vessel Coronary Disease and Left Ventricular Dysfunction.

Authors:  Noa P Yee; Andrea M Siu; James Davis; John Kao
Journal:  Hawaii J Med Public Health       Date:  2016-09

5.  Preferred Revascularization Strategies in Patients with Ischemic Heart Failure: A Meta-Analysis.

Authors:  Jie Xiao; Fen Xu; Chuan-Lei Yang; Wei-Qiang Chen; Xing Chen; Hua Zhang; Zhan-Jie Wei; Jin-Ping Liu
Journal:  Curr Med Sci       Date:  2018-10-20

6.  Current Practice of State-of-the-Art Coronary Revascularization in Patients with Heart Failure.

Authors:  Sérgio Costa Rayol; Michel Pompeu Barros Oliveira Sá; Luiz Rafael Pereira Cavalcanti; Felipe Augusto Santos Saragiotto; Roberto Gouvea Silva Diniz; Frederico Browne Correia de Araújo E Sá; Alexandre Motta de Menezes; Ricardo Carvalho Lima
Journal:  Braz J Cardiovasc Surg       Date:  2019 Jan-Feb

7.  Coronary Artery Bypass Graft Surgery Improves Survival Without Increasing the Risk of Stroke in Patients with Ischemic Heart Failure in Comparison to Percutaneous Coronary Intervention: A Meta-Analysis With 54,173 Patients.

Authors:  Michel Pompeu Barros Oliveira Sá; Álvaro Monteiro Perazzo; Felipe Augusto Santos Saragiotto; Luiz Rafael Pereira Cavalcanti; Antônio Carlos Escorel Almeida; Jéssica Cordeiro Siqueira Campos; Paulo Guilherme Bezerra Braga; Sérgio da Costa Rayol; Roberto Gouvea Silva Diniz; Frederico Browne Correia Araújo Sá; Ricardo Carvalho Lima
Journal:  Braz J Cardiovasc Surg       Date:  2019-08-27

8.  Determinants of outcome in patients with chronic ischemic left ventricular dysfunction undergone percutaneous coronary interventions.

Authors:  Enrico Ammirati; Valentina Guida; Azeem Latib; Francesco Moroni; Francesco Arioli; Isabella Scotti; Ornella E Rimoldi; Antonio Colombo; Paolo G Camici
Journal:  BMC Cardiovasc Disord       Date:  2015-10-26       Impact factor: 2.298

9.  Impact of severe left ventricular dysfunction on in-hospital and mid-term outcomes of Chinese patients undergoing first isolated off-pump coronary artery bypass grafting.

Authors:  Qiang Ji; Li Min Xia; Yun Qing Shi; Run Hua Ma; Jin Qiang Shen; Wen Jun Ding; Chun Sheng Wang
Journal:  J Cardiothorac Surg       Date:  2017-10-10       Impact factor: 1.637

10.  Glycemic control and risk factors for in-hospital mortality and vascular complications after coronary artery bypass grafting in patients with and without preexisting diabetes.

Authors:  Yanyan Chen; Heng Zhang; Xiaopei Hou; Xiaojue Li; Xin Qian; Xinxing Feng; Shuqian Liu; Na Shi; Wei Zhao; Shengshou Hu; Zhe Zheng; Guangwei Li
Journal:  J Diabetes       Date:  2020-09-14       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.